KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cardinal Health (CAH) Minority Interest (2016 - 2025)

Cardinal Health (CAH) has disclosed Minority Interest for 11 consecutive years, with $184.0 million as the latest value for Q4 2025.

  • Quarterly Minority Interest rose 162.86% to $184.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $184.0 million through Dec 2025, up 162.86% year-over-year, with the annual reading at $147.0 million for FY2025, 14600.0% up from the prior year.
  • Minority Interest hit $184.0 million in Q4 2025 for Cardinal Health, up from $148.0 million in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of $1.0 billion in Q1 2025 to a low of $1.0 million in Q3 2022.
  • Historically, Minority Interest has averaged $81.6 million across 5 years, with a median of $3.0 million in 2021.
  • Biggest five-year swings in Minority Interest: crashed 75.0% in 2022 and later surged 34900.0% in 2025.
  • Year by year, Minority Interest stood at $4.0 million in 2021, then plummeted by 75.0% to $1.0 million in 2022, then surged by 100.0% to $2.0 million in 2023, then soared by 3400.0% to $70.0 million in 2024, then surged by 162.86% to $184.0 million in 2025.
  • Business Quant data shows Minority Interest for CAH at $184.0 million in Q4 2025, $148.0 million in Q3 2025, and $147.0 million in Q2 2025.